[HTML][HTML] An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related …
A Efstathiou, N Gaboriaud-Kolar, D Smirlis… - Parasites & vectors, 2014 - Springer
Background In search of new antiparasitic agents for overcoming the limitations of current
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
[HTML][HTML] An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related …
A Efstathiou, N Gaboriaud-Kolar… - Parasites & …, 2014 - parasitesandvectors.biomedcentral …
In search of new antiparasitic agents for overcoming the limitations of current leishmaniasis
chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime (6BIO) and …
chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime (6BIO) and …
An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein …
A Efstathiou, N Gaboriaud-Kolar, D Smirlis… - Parasites & …, 2014 - europepmc.org
Background In search of new antiparasitic agents for overcoming the limitations of current
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein …
A Efstathiou, N Gaboriaud-Kolar, D Smirlis… - Parasites & …, 2014 - search.ebscohost.com
Background In search of new antiparasitic agents for overcoming the limitations of current
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime (6 …
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime (6 …
[PDF][PDF] An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related …
A Efstathiou, N Gaboriaud-Kolar, D Smirlis… - 2014 - academia.edu
Background: In search of new antiparasitic agents for overcoming the limitations of current
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
[PDF][PDF] An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related …
A Efstathiou, N Gaboriaud-Kolar, D Smirlis… - 2014 - Citeseer
Background: In search of new antiparasitic agents for overcoming the limitations of current
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
[PDF][PDF] An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related …
A Efstathiou, N Gaboriaud-Kolar, D Smirlis… - 2014 - tekhelet.com
Background: In search of new antiparasitic agents for overcoming the limitations of current
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related protein …
A Efstathiou, N Gaboriaud-Kolar, D Smirlis… - 2014 - cabidigitallibrary.org
Background: In search of new antiparasitic agents for overcoming the limitations of current
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3′-oxime …
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3′-oxime …
[PDF][PDF] An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related …
A Efstathiou, N Gaboriaud-Kolar, D Smirlis… - 2014 - researchgate.net
Background: In search of new antiparasitic agents for overcoming the limitations of current
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
[HTML][HTML] An inhibitor-driven study for enhancing the selectivity of indirubin derivatives towards leishmanial Glycogen Synthase Kinase-3 over leishmanial cdc2-related …
A Efstathiou, N Gaboriaud-Kolar, D Smirlis… - Parasites & …, 2014 - ncbi.nlm.nih.gov
Background In search of new antiparasitic agents for overcoming the limitations of current
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …
leishmaniasis chemotherapy, we have previously shown that 6-bromoindirubin-3'-oxime …